IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS

Children with bronchopulmonary dysplasia belong to the risk group of severe respiratory-syncytial viral infection (RSV). World experience and authors' own clinical data show that seasonal immunoprophylaxis of RSV infection's severe course by palivizumab in these patients allows reducing fr...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Baranov, I. V. Davydova, T. V. Turti, L. S. Namazova-Baranova, V. V. Altunin, E. P. Zimina, E. V. Pavlyukova
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2012-12-01
Series:	Педиатрическая фармакология
Subjects:	respiratory-syncytial virus bronchopulmonary dysplasia acute respiratory viral infection respiratory function palivizumab
Online Access:	https://www.pedpharma.ru/jour/article/view/268
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PREVENTIVE STRATEGIES IN THE STAGES OF FORMATION AND COURSE OF BRONCHOPULMONARY DYSPLASIA
by: I. V. Davydova, et al.
Published: (2014-03-01)

Effectiveness of palivizumab immunoprophylaxis in infants with respiratory syncytial virus disease in Colombia
by: Juan Gabriel Piñeros, et al.
Published: (2021-11-01)

Modern Approaches in management of Children with Acute Bronchiolitis
by: Alexander A. Baranov, et al.
Published: (2020-02-01)

Improving the quality of care of respiratory syncytial virus in the neonatal and pediatric populations globally
by: Fungwe Jah, et al.
Published: (2025-05-01)

Extrapulmonary Conditions, Concomitant of Bronchopulmonary Dysplasia, in Babies of the First 3 Years of Life: Results of a Retrospective Cross-Sectional Study
by: K. A. Kazakova, et al.
Published: (2016-12-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
by: I. V. Babachenko, et al.
Published: (2018-04-01)

Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons
by: V. K. Pozharishchenskaya, et al.
Published: (2017-05-01)

A Review of Recent Cluster of Hospitalization-related Respiratory Syncytial Virus Infection Post-COVID-19: A Cross-sectional Study
by: Khalid Al Dhuhli, et al.
Published: (2024-01-01)

Genomic characterization and phylogenetic analysis of respiratory syncytial virus F gene in Sri Lanka: a comparative study
by: Thejanee Perera, et al.
Published: (2025-07-01)

The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
by: V. V. Vysochinskayа, et al.
Published: (2014-09-01)

Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01)

Out-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses
by: Angela M. Rose, et al.
Published: (2025-08-01)

Turkish pediatricians’ knowledge, attitudes, and awareness of respiratory syncytial virus (RSV) infection and immunization strategies: a cross-sectional study
by: İsmail Yıldız, et al.
Published: (2025-05-01)

The Effects of HFOV-VG vs HFOV on Bronchopulmonary Dysplasia and Neurobehavioral Development in Preterm Infants with Perinatal Acute Respiratory Distress Syndrome
by: Tao M, et al.
Published: (2025-08-01)

Pediatric respiratory syncytial virus rehospitalization rate – a retrospective observational study from Switzerland
by: Naomi Rupp, et al.
Published: (2025-07-01)

Application broncho-phonography investigation for an estimation of respiratory frustration at immature infants with a respiratory distress-syndrome
by: Ye. B. Pavlinova, et al.
Published: (2010-06-01)

Evolutionary trajectory and spread of respiratory syncytial virus group A in neonatal cohorts in Pakistan amidst the COVID-19 pandemic
by: Sana Tamim, et al.
Published: (2025-07-01)

The Most Important Risk Factors and Associated Morbidities of Bronchopulmonary Dysplasia, the Never Ending Problem of Preterms
by: Ayşen Bayrak, et al.
Published: (2025-08-01)

Research hotspots and global trends in respiratory syncytial virus over past five years
by: Xiaoli Tao, et al.
Published: (2025-08-01)

Acute Bronchiolitis in Children. Current Approaches to Diagnosis and Therapy
by: A. A. Baranov, et al.
Published: (2015-11-01)

Bronchopulmonary Pathology Prevalence Among Premature infants and Estimation of Prophylactic Efficacy and Reactogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Premature infants with Bronchopulmonary Dysplasia
by: Vladislav V. Semerikov, et al.
Published: (2020-02-01)

Demographic and Diagnostic Predictors of Respiratory Syncytial Virus in Children of Less than 2 Years Presenting with Acute Respiratory Tract Infection
by: Nikhil Raj, et al.
Published: (2023-06-01)

Estimating the respiratory syncytial virus-associated hospitalisation burden in older adults in European countries: a systematic analysis
by: Tiantian Zhang, et al.
Published: (2025-08-01)

Enteroviruses in the etiology of acute respiratory viral infections in children, Novosibirsk, Russia
by: O. G. Kurskaya, et al.
Published: (2024-01-01)

Respiratory viral infections in lung transplantation: Recent advances in epidemiology, clinical impact, and therapeutic approaches
by: Hannah Bahakel, MD, et al.
Published: (2025-11-01)

Hospitalizations for respiratory syncytial virus (RSV) in Sicily from 2008 to 2021: clinical features and predictors of severity
by: Anna Condemi, et al.
Published: (2025-07-01)

Features of current and intensive therapy of new coronavirus infection in children with comorbidities (clinical cases)
by: K. V. Pshenisnov, et al.
Published: (2020-08-01)

Molecular characterization of human respiratory syncytial virus in Mexico (season 2023–2024) through whole-genome sequencing
by: Evelyn Rivera-Toledo, et al.
Published: (2025-07-01)

An overview of respiratory syncytial virus infections in Saudi Arabia
by: Anwar Ahmed, et al.
Published: (2018-11-01)

Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018
by: Elena Alexandrovna Prokopyeva, et al.
Published: (2023-02-01)

CULTURAL PROPERTIES OF BOVINE RESPIRATORY SYNCYTIAL VIRUS STRAIN AB1908
by: V. V. Kirpichenko, et al.
Published: (2019-12-01)

Socio-economic burden of respiratory syncytial viral infection of the lower respiratory tract in children aged from birth to 5 years in the Russian Federation: modeling results
by: V. I. Ignatyeva, et al.
Published: (2024-02-01)

Exploring the Contribution of TLR7 to Sex-Based Disparities in Respiratory Syncytial Virus (RSV)-Induced Inflammation and Immunity
by: Mark A. Miles, et al.
Published: (2025-03-01)

Enhanced vs. standard low dose dexamethasone treatment on respiratory outcomes of preterm infants with bronchopulmonary dysplasia
by: Sezgin Gunes, et al.
Published: (2025-08-01)

Effect of respiratory microflorae colonization on short and long‐time outcomes of respiratory syncytial virus infection in children: A scoping review
by: Lidan Gan, et al.
Published: (2024-12-01)

The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Older Adults in Italy
by: Anna Puggina, et al.
Published: (2025-02-01)

Shorter Intervals of Antenatal Corticosteroid Administration Can Influence Short- and Long-Term Outcomes in Premature Infants
by: Katrina Kraft, et al.
Published: (2024-04-01)

CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN THE FIRST YEAR OF LIFE
by: I. V. Babachenko, et al.
Published: (2018-10-01)

PROPHYLAXIS OF ACUTE RESPIRATORY TRACT INFECTIONS IN CHILDREN WITH RECURRENT BRONCHOPULMONARY DISORDERS
by: A. Yu. Simonova
Published: (2013-07-01)

Exploring the mechanism of matrine on lung inflammation in mice infected with respiratory syncytial virus by regulating PI3K/AKT signaling pathway
by: YU Yanmei, et al.
Published: (2024-07-01)